76 results
Page 3 of 4
8-K
EX-99.1
izhdmaup1y0
7 May 19
Prothena Reports First Quarter 2019 Financial Results and Provides R&D Update
4:09pm
8-K
EX-99.1
46ims dstdl
18 Apr 19
Prothena Reports Results from the Phase 3 VITAL Amyloidosis Study of NEOD001 (birtamimab) in AL Amyloidosis
4:06pm
8-K
EX-99.1
dbf7 qjcnw1l02pb9ny
15 Dec 14
Prothena Receives FDA Fast Track Designation for NEOD001, a Monoclonal Antibody for the Treatment of Patients with AL Amyloidosis
12:00am
8-K
EX-99.1
nbjq3g m28o
2 Dec 14
Other Events
12:00am
8-K
EX-1.1
lr2ej3
25 Jun 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
vuw300 o4vfgzbg5er
18 Mar 14
Prothena Announces Clinical Data to be Presented at the International Symposium on Amyloidosis
12:00am
424B3
ovvd6xedo68zer eih
29 Jan 14
Prospectus supplement
12:00am